Global mRNA Vaccines for Infectious Diseases Market Growth (Status and Outlook) 2023-2029
The report requires updating with new data and is sent in 48 hours after order is placed.
LPI (LP Information)' newest research report, the “mRNA Vaccines for Infectious Diseases Industry Forecast” looks at past sales and reviews total world mRNA Vaccines for Infectious Diseases sales in 2022, providing a comprehensive analysis by region and market sector of projected mRNA Vaccines for Infectious Diseases sales for 2023 through 2029. With mRNA Vaccines for Infectious Diseases sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world mRNA Vaccines for Infectious Diseases industry.
This Insight Report provides a comprehensive analysis of the global mRNA Vaccines for Infectious Diseases landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on mRNA Vaccines for Infectious Diseases portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global mRNA Vaccines for Infectious Diseases market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for mRNA Vaccines for Infectious Diseases and breaks down the forecast by type, by application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global mRNA Vaccines for Infectious Diseases.
The global mRNA Vaccines for Infectious Diseases market size is projected to grow from US$ million in 2022 to US$ million in 2029; it is expected to grow at a CAGR of % from 2023 to 2029.
United States market for mRNA Vaccines for Infectious Diseases is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.
China market for mRNA Vaccines for Infectious Diseases is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.
Europe market for mRNA Vaccines for Infectious Diseases is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.
Global key mRNA Vaccines for Infectious Diseases players cover Moderna Therapeutics, CureVac, Translate Bio, BioNTech, Sangamo Therapeutics, Argos Therapeutics, In-Cell-Art, eTheRNA and Ethris, etc. In terms of revenue, the global two largest companies occupied for a share nearly % in 2022.
This report presents a comprehensive overview, market shares, and growth opportunities of mRNA Vaccines for Infectious Diseases market by product type, application, key players and key regions and countries.
Market Segmentation:
Segmentation by type
LPI (LP Information)' newest research report, the “mRNA Vaccines for Infectious Diseases Industry Forecast” looks at past sales and reviews total world mRNA Vaccines for Infectious Diseases sales in 2022, providing a comprehensive analysis by region and market sector of projected mRNA Vaccines for Infectious Diseases sales for 2023 through 2029. With mRNA Vaccines for Infectious Diseases sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world mRNA Vaccines for Infectious Diseases industry.
This Insight Report provides a comprehensive analysis of the global mRNA Vaccines for Infectious Diseases landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on mRNA Vaccines for Infectious Diseases portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global mRNA Vaccines for Infectious Diseases market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for mRNA Vaccines for Infectious Diseases and breaks down the forecast by type, by application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global mRNA Vaccines for Infectious Diseases.
The global mRNA Vaccines for Infectious Diseases market size is projected to grow from US$ million in 2022 to US$ million in 2029; it is expected to grow at a CAGR of % from 2023 to 2029.
United States market for mRNA Vaccines for Infectious Diseases is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.
China market for mRNA Vaccines for Infectious Diseases is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.
Europe market for mRNA Vaccines for Infectious Diseases is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.
Global key mRNA Vaccines for Infectious Diseases players cover Moderna Therapeutics, CureVac, Translate Bio, BioNTech, Sangamo Therapeutics, Argos Therapeutics, In-Cell-Art, eTheRNA and Ethris, etc. In terms of revenue, the global two largest companies occupied for a share nearly % in 2022.
This report presents a comprehensive overview, market shares, and growth opportunities of mRNA Vaccines for Infectious Diseases market by product type, application, key players and key regions and countries.
Market Segmentation:
Segmentation by type
- Infectious Disease Vaccines
- Cancer Vaccines
- Infectious Disease
- Cancer
- Americas
- United States
- Canada
- Mexico
- Brazil
- APAC
- China
- Japan
- Korea
- Southeast Asia
- India
- Australia
- Europe
- Germany
- France
- UK
- Italy
- Russia
- Middle East & Africa
- Egypt
- South Africa
- Israel
- Turkey
- GCC Countries
- Moderna Therapeutics
- CureVac
- Translate Bio
- BioNTech
- Sangamo Therapeutics
- Argos Therapeutics
- In-Cell-Art
- eTheRNA
- Ethris
- Tiba Biotechnology
1 SCOPE OF THE REPORT
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 EXECUTIVE SUMMARY
2.1 World Market Overview
2.1.1 Global mRNA Vaccines for Infectious Diseases Market Size 2018-2029
2.1.2 mRNA Vaccines for Infectious Diseases Market Size CAGR by Region 2018 VS 2022 VS 2029
2.2 mRNA Vaccines for Infectious Diseases Segment by Type
2.2.1 Infectious Disease Vaccines
2.2.2 Cancer Vaccines
2.3 mRNA Vaccines for Infectious Diseases Market Size by Type
2.3.1 mRNA Vaccines for Infectious Diseases Market Size CAGR by Type (2018 VS 2022 VS 2029)
2.3.2 Global mRNA Vaccines for Infectious Diseases Market Size Market Share by Type (2018-2023)
2.4 mRNA Vaccines for Infectious Diseases Segment by Application
2.4.1 Infectious Disease
2.4.2 Cancer
2.5 mRNA Vaccines for Infectious Diseases Market Size by Application
2.5.1 mRNA Vaccines for Infectious Diseases Market Size CAGR by Application (2018 VS 2022 VS 2029)
2.5.2 Global mRNA Vaccines for Infectious Diseases Market Size Market Share by Application (2018-2023)
3 MRNA VACCINES FOR INFECTIOUS DISEASES MARKET SIZE BY PLAYER
3.1 mRNA Vaccines for Infectious Diseases Market Size Market Share by Players
3.1.1 Global mRNA Vaccines for Infectious Diseases Revenue by Players (2018-2023)
3.1.2 Global mRNA Vaccines for Infectious Diseases Revenue Market Share by Players (2018-2023)
3.2 Global mRNA Vaccines for Infectious Diseases Key Players Head office and Products Offered
3.3 Market Concentration Rate Analysis
3.3.1 Competition Landscape Analysis
3.3.2 Concentration Ratio (CR3, CR5 and CR10) & (2021-2023)
3.4 New Products and Potential Entrants
3.5 Mergers & Acquisitions, Expansion
4 MRNA VACCINES FOR INFECTIOUS DISEASES BY REGIONS
4.1 mRNA Vaccines for Infectious Diseases Market Size by Regions (2018-2023)
4.2 Americas mRNA Vaccines for Infectious Diseases Market Size Growth (2018-2023)
4.3 APAC mRNA Vaccines for Infectious Diseases Market Size Growth (2018-2023)
4.4 Europe mRNA Vaccines for Infectious Diseases Market Size Growth (2018-2023)
4.5 Middle East & Africa mRNA Vaccines for Infectious Diseases Market Size Growth (2018-2023)
5 AMERICAS
5.1 Americas mRNA Vaccines for Infectious Diseases Market Size by Country (2018-2023)
5.2 Americas mRNA Vaccines for Infectious Diseases Market Size by Type (2018-2023)
5.3 Americas mRNA Vaccines for Infectious Diseases Market Size by Application (2018-2023)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC mRNA Vaccines for Infectious Diseases Market Size by Region (2018-2023)
6.2 APAC mRNA Vaccines for Infectious Diseases Market Size by Type (2018-2023)
6.3 APAC mRNA Vaccines for Infectious Diseases Market Size by Application (2018-2023)
6.4 China
6.5 Japan
6.6 Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
7 EUROPE
7.1 Europe mRNA Vaccines for Infectious Diseases by Country (2018-2023)
7.2 Europe mRNA Vaccines for Infectious Diseases Market Size by Type (2018-2023)
7.3 Europe mRNA Vaccines for Infectious Diseases Market Size by Application (2018-2023)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 MIDDLE EAST & AFRICA
8.1 Middle East & Africa mRNA Vaccines for Infectious Diseases by Region (2018-2023)
8.2 Middle East & Africa mRNA Vaccines for Infectious Diseases Market Size by Type (2018-2023)
8.3 Middle East & Africa mRNA Vaccines for Infectious Diseases Market Size by Application (2018-2023)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 MARKET DRIVERS, CHALLENGES AND TRENDS
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 GLOBAL MRNA VACCINES FOR INFECTIOUS DISEASES MARKET FORECAST
10.1 Global mRNA Vaccines for Infectious Diseases Forecast by Regions (2024-2029)
10.1.1 Global mRNA Vaccines for Infectious Diseases Forecast by Regions (2024-2029)
10.1.2 Americas mRNA Vaccines for Infectious Diseases Forecast
10.1.3 APAC mRNA Vaccines for Infectious Diseases Forecast
10.1.4 Europe mRNA Vaccines for Infectious Diseases Forecast
10.1.5 Middle East & Africa mRNA Vaccines for Infectious Diseases Forecast
10.2 Americas mRNA Vaccines for Infectious Diseases Forecast by Country (2024-2029)
10.2.1 United States mRNA Vaccines for Infectious Diseases Market Forecast
10.2.2 Canada mRNA Vaccines for Infectious Diseases Market Forecast
10.2.3 Mexico mRNA Vaccines for Infectious Diseases Market Forecast
10.2.4 Brazil mRNA Vaccines for Infectious Diseases Market Forecast
10.3 APAC mRNA Vaccines for Infectious Diseases Forecast by Region (2024-2029)
10.3.1 China mRNA Vaccines for Infectious Diseases Market Forecast
10.3.2 Japan mRNA Vaccines for Infectious Diseases Market Forecast
10.3.3 Korea mRNA Vaccines for Infectious Diseases Market Forecast
10.3.4 Southeast Asia mRNA Vaccines for Infectious Diseases Market Forecast
10.3.5 India mRNA Vaccines for Infectious Diseases Market Forecast
10.3.6 Australia mRNA Vaccines for Infectious Diseases Market Forecast
10.4 Europe mRNA Vaccines for Infectious Diseases Forecast by Country (2024-2029)
10.4.1 Germany mRNA Vaccines for Infectious Diseases Market Forecast
10.4.2 France mRNA Vaccines for Infectious Diseases Market Forecast
10.4.3 UK mRNA Vaccines for Infectious Diseases Market Forecast
10.4.4 Italy mRNA Vaccines for Infectious Diseases Market Forecast
10.4.5 Russia mRNA Vaccines for Infectious Diseases Market Forecast
10.5 Middle East & Africa mRNA Vaccines for Infectious Diseases Forecast by Region (2024-2029)
10.5.1 Egypt mRNA Vaccines for Infectious Diseases Market Forecast
10.5.2 South Africa mRNA Vaccines for Infectious Diseases Market Forecast
10.5.3 Israel mRNA Vaccines for Infectious Diseases Market Forecast
10.5.4 Turkey mRNA Vaccines for Infectious Diseases Market Forecast
10.5.5 GCC Countries mRNA Vaccines for Infectious Diseases Market Forecast
10.6 Global mRNA Vaccines for Infectious Diseases Forecast by Type (2024-2029)
10.7 Global mRNA Vaccines for Infectious Diseases Forecast by Application (2024-2029)
11 KEY PLAYERS ANALYSIS
11.1 Moderna Therapeutics
11.1.1 Moderna Therapeutics Company Information
11.1.2 Moderna Therapeutics mRNA Vaccines for Infectious Diseases Product Offered
11.1.3 Moderna Therapeutics mRNA Vaccines for Infectious Diseases Revenue, Gross Margin and Market Share (2018-2023)
11.1.4 Moderna Therapeutics Main Business Overview
11.1.5 Moderna Therapeutics Latest Developments
11.2 CureVac
11.2.1 CureVac Company Information
11.2.2 CureVac mRNA Vaccines for Infectious Diseases Product Offered
11.2.3 CureVac mRNA Vaccines for Infectious Diseases Revenue, Gross Margin and Market Share (2018-2023)
11.2.4 CureVac Main Business Overview
11.2.5 CureVac Latest Developments
11.3 Translate Bio
11.3.1 Translate Bio Company Information
11.3.2 Translate Bio mRNA Vaccines for Infectious Diseases Product Offered
11.3.3 Translate Bio mRNA Vaccines for Infectious Diseases Revenue, Gross Margin and Market Share (2018-2023)
11.3.4 Translate Bio Main Business Overview
11.3.5 Translate Bio Latest Developments
11.4 BioNTech
11.4.1 BioNTech Company Information
11.4.2 BioNTech mRNA Vaccines for Infectious Diseases Product Offered
11.4.3 BioNTech mRNA Vaccines for Infectious Diseases Revenue, Gross Margin and Market Share (2018-2023)
11.4.4 BioNTech Main Business Overview
11.4.5 BioNTech Latest Developments
11.5 Sangamo Therapeutics
11.5.1 Sangamo Therapeutics Company Information
11.5.2 Sangamo Therapeutics mRNA Vaccines for Infectious Diseases Product Offered
11.5.3 Sangamo Therapeutics mRNA Vaccines for Infectious Diseases Revenue, Gross Margin and Market Share (2018-2023)
11.5.4 Sangamo Therapeutics Main Business Overview
11.5.5 Sangamo Therapeutics Latest Developments
11.6 Argos Therapeutics
11.6.1 Argos Therapeutics Company Information
11.6.2 Argos Therapeutics mRNA Vaccines for Infectious Diseases Product Offered
11.6.3 Argos Therapeutics mRNA Vaccines for Infectious Diseases Revenue, Gross Margin and Market Share (2018-2023)
11.6.4 Argos Therapeutics Main Business Overview
11.6.5 Argos Therapeutics Latest Developments
11.7 In-Cell-Art
11.7.1 In-Cell-Art Company Information
11.7.2 In-Cell-Art mRNA Vaccines for Infectious Diseases Product Offered
11.7.3 In-Cell-Art mRNA Vaccines for Infectious Diseases Revenue, Gross Margin and Market Share (2018-2023)
11.7.4 In-Cell-Art Main Business Overview
11.7.5 In-Cell-Art Latest Developments
11.8 eTheRNA
11.8.1 eTheRNA Company Information
11.8.2 eTheRNA mRNA Vaccines for Infectious Diseases Product Offered
11.8.3 eTheRNA mRNA Vaccines for Infectious Diseases Revenue, Gross Margin and Market Share (2018-2023)
11.8.4 eTheRNA Main Business Overview
11.8.5 eTheRNA Latest Developments
11.9 Ethris
11.9.1 Ethris Company Information
11.9.2 Ethris mRNA Vaccines for Infectious Diseases Product Offered
11.9.3 Ethris mRNA Vaccines for Infectious Diseases Revenue, Gross Margin and Market Share (2018-2023)
11.9.4 Ethris Main Business Overview
11.9.5 Ethris Latest Developments
11.10 Tiba Biotechnology
11.10.1 Tiba Biotechnology Company Information
11.10.2 Tiba Biotechnology mRNA Vaccines for Infectious Diseases Product Offered
11.10.3 Tiba Biotechnology mRNA Vaccines for Infectious Diseases Revenue, Gross Margin and Market Share (2018-2023)
11.10.4 Tiba Biotechnology Main Business Overview
11.10.5 Tiba Biotechnology Latest Developments
12 RESEARCH FINDINGS AND CONCLUSION
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 EXECUTIVE SUMMARY
2.1 World Market Overview
2.1.1 Global mRNA Vaccines for Infectious Diseases Market Size 2018-2029
2.1.2 mRNA Vaccines for Infectious Diseases Market Size CAGR by Region 2018 VS 2022 VS 2029
2.2 mRNA Vaccines for Infectious Diseases Segment by Type
2.2.1 Infectious Disease Vaccines
2.2.2 Cancer Vaccines
2.3 mRNA Vaccines for Infectious Diseases Market Size by Type
2.3.1 mRNA Vaccines for Infectious Diseases Market Size CAGR by Type (2018 VS 2022 VS 2029)
2.3.2 Global mRNA Vaccines for Infectious Diseases Market Size Market Share by Type (2018-2023)
2.4 mRNA Vaccines for Infectious Diseases Segment by Application
2.4.1 Infectious Disease
2.4.2 Cancer
2.5 mRNA Vaccines for Infectious Diseases Market Size by Application
2.5.1 mRNA Vaccines for Infectious Diseases Market Size CAGR by Application (2018 VS 2022 VS 2029)
2.5.2 Global mRNA Vaccines for Infectious Diseases Market Size Market Share by Application (2018-2023)
3 MRNA VACCINES FOR INFECTIOUS DISEASES MARKET SIZE BY PLAYER
3.1 mRNA Vaccines for Infectious Diseases Market Size Market Share by Players
3.1.1 Global mRNA Vaccines for Infectious Diseases Revenue by Players (2018-2023)
3.1.2 Global mRNA Vaccines for Infectious Diseases Revenue Market Share by Players (2018-2023)
3.2 Global mRNA Vaccines for Infectious Diseases Key Players Head office and Products Offered
3.3 Market Concentration Rate Analysis
3.3.1 Competition Landscape Analysis
3.3.2 Concentration Ratio (CR3, CR5 and CR10) & (2021-2023)
3.4 New Products and Potential Entrants
3.5 Mergers & Acquisitions, Expansion
4 MRNA VACCINES FOR INFECTIOUS DISEASES BY REGIONS
4.1 mRNA Vaccines for Infectious Diseases Market Size by Regions (2018-2023)
4.2 Americas mRNA Vaccines for Infectious Diseases Market Size Growth (2018-2023)
4.3 APAC mRNA Vaccines for Infectious Diseases Market Size Growth (2018-2023)
4.4 Europe mRNA Vaccines for Infectious Diseases Market Size Growth (2018-2023)
4.5 Middle East & Africa mRNA Vaccines for Infectious Diseases Market Size Growth (2018-2023)
5 AMERICAS
5.1 Americas mRNA Vaccines for Infectious Diseases Market Size by Country (2018-2023)
5.2 Americas mRNA Vaccines for Infectious Diseases Market Size by Type (2018-2023)
5.3 Americas mRNA Vaccines for Infectious Diseases Market Size by Application (2018-2023)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC mRNA Vaccines for Infectious Diseases Market Size by Region (2018-2023)
6.2 APAC mRNA Vaccines for Infectious Diseases Market Size by Type (2018-2023)
6.3 APAC mRNA Vaccines for Infectious Diseases Market Size by Application (2018-2023)
6.4 China
6.5 Japan
6.6 Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
7 EUROPE
7.1 Europe mRNA Vaccines for Infectious Diseases by Country (2018-2023)
7.2 Europe mRNA Vaccines for Infectious Diseases Market Size by Type (2018-2023)
7.3 Europe mRNA Vaccines for Infectious Diseases Market Size by Application (2018-2023)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 MIDDLE EAST & AFRICA
8.1 Middle East & Africa mRNA Vaccines for Infectious Diseases by Region (2018-2023)
8.2 Middle East & Africa mRNA Vaccines for Infectious Diseases Market Size by Type (2018-2023)
8.3 Middle East & Africa mRNA Vaccines for Infectious Diseases Market Size by Application (2018-2023)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 MARKET DRIVERS, CHALLENGES AND TRENDS
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 GLOBAL MRNA VACCINES FOR INFECTIOUS DISEASES MARKET FORECAST
10.1 Global mRNA Vaccines for Infectious Diseases Forecast by Regions (2024-2029)
10.1.1 Global mRNA Vaccines for Infectious Diseases Forecast by Regions (2024-2029)
10.1.2 Americas mRNA Vaccines for Infectious Diseases Forecast
10.1.3 APAC mRNA Vaccines for Infectious Diseases Forecast
10.1.4 Europe mRNA Vaccines for Infectious Diseases Forecast
10.1.5 Middle East & Africa mRNA Vaccines for Infectious Diseases Forecast
10.2 Americas mRNA Vaccines for Infectious Diseases Forecast by Country (2024-2029)
10.2.1 United States mRNA Vaccines for Infectious Diseases Market Forecast
10.2.2 Canada mRNA Vaccines for Infectious Diseases Market Forecast
10.2.3 Mexico mRNA Vaccines for Infectious Diseases Market Forecast
10.2.4 Brazil mRNA Vaccines for Infectious Diseases Market Forecast
10.3 APAC mRNA Vaccines for Infectious Diseases Forecast by Region (2024-2029)
10.3.1 China mRNA Vaccines for Infectious Diseases Market Forecast
10.3.2 Japan mRNA Vaccines for Infectious Diseases Market Forecast
10.3.3 Korea mRNA Vaccines for Infectious Diseases Market Forecast
10.3.4 Southeast Asia mRNA Vaccines for Infectious Diseases Market Forecast
10.3.5 India mRNA Vaccines for Infectious Diseases Market Forecast
10.3.6 Australia mRNA Vaccines for Infectious Diseases Market Forecast
10.4 Europe mRNA Vaccines for Infectious Diseases Forecast by Country (2024-2029)
10.4.1 Germany mRNA Vaccines for Infectious Diseases Market Forecast
10.4.2 France mRNA Vaccines for Infectious Diseases Market Forecast
10.4.3 UK mRNA Vaccines for Infectious Diseases Market Forecast
10.4.4 Italy mRNA Vaccines for Infectious Diseases Market Forecast
10.4.5 Russia mRNA Vaccines for Infectious Diseases Market Forecast
10.5 Middle East & Africa mRNA Vaccines for Infectious Diseases Forecast by Region (2024-2029)
10.5.1 Egypt mRNA Vaccines for Infectious Diseases Market Forecast
10.5.2 South Africa mRNA Vaccines for Infectious Diseases Market Forecast
10.5.3 Israel mRNA Vaccines for Infectious Diseases Market Forecast
10.5.4 Turkey mRNA Vaccines for Infectious Diseases Market Forecast
10.5.5 GCC Countries mRNA Vaccines for Infectious Diseases Market Forecast
10.6 Global mRNA Vaccines for Infectious Diseases Forecast by Type (2024-2029)
10.7 Global mRNA Vaccines for Infectious Diseases Forecast by Application (2024-2029)
11 KEY PLAYERS ANALYSIS
11.1 Moderna Therapeutics
11.1.1 Moderna Therapeutics Company Information
11.1.2 Moderna Therapeutics mRNA Vaccines for Infectious Diseases Product Offered
11.1.3 Moderna Therapeutics mRNA Vaccines for Infectious Diseases Revenue, Gross Margin and Market Share (2018-2023)
11.1.4 Moderna Therapeutics Main Business Overview
11.1.5 Moderna Therapeutics Latest Developments
11.2 CureVac
11.2.1 CureVac Company Information
11.2.2 CureVac mRNA Vaccines for Infectious Diseases Product Offered
11.2.3 CureVac mRNA Vaccines for Infectious Diseases Revenue, Gross Margin and Market Share (2018-2023)
11.2.4 CureVac Main Business Overview
11.2.5 CureVac Latest Developments
11.3 Translate Bio
11.3.1 Translate Bio Company Information
11.3.2 Translate Bio mRNA Vaccines for Infectious Diseases Product Offered
11.3.3 Translate Bio mRNA Vaccines for Infectious Diseases Revenue, Gross Margin and Market Share (2018-2023)
11.3.4 Translate Bio Main Business Overview
11.3.5 Translate Bio Latest Developments
11.4 BioNTech
11.4.1 BioNTech Company Information
11.4.2 BioNTech mRNA Vaccines for Infectious Diseases Product Offered
11.4.3 BioNTech mRNA Vaccines for Infectious Diseases Revenue, Gross Margin and Market Share (2018-2023)
11.4.4 BioNTech Main Business Overview
11.4.5 BioNTech Latest Developments
11.5 Sangamo Therapeutics
11.5.1 Sangamo Therapeutics Company Information
11.5.2 Sangamo Therapeutics mRNA Vaccines for Infectious Diseases Product Offered
11.5.3 Sangamo Therapeutics mRNA Vaccines for Infectious Diseases Revenue, Gross Margin and Market Share (2018-2023)
11.5.4 Sangamo Therapeutics Main Business Overview
11.5.5 Sangamo Therapeutics Latest Developments
11.6 Argos Therapeutics
11.6.1 Argos Therapeutics Company Information
11.6.2 Argos Therapeutics mRNA Vaccines for Infectious Diseases Product Offered
11.6.3 Argos Therapeutics mRNA Vaccines for Infectious Diseases Revenue, Gross Margin and Market Share (2018-2023)
11.6.4 Argos Therapeutics Main Business Overview
11.6.5 Argos Therapeutics Latest Developments
11.7 In-Cell-Art
11.7.1 In-Cell-Art Company Information
11.7.2 In-Cell-Art mRNA Vaccines for Infectious Diseases Product Offered
11.7.3 In-Cell-Art mRNA Vaccines for Infectious Diseases Revenue, Gross Margin and Market Share (2018-2023)
11.7.4 In-Cell-Art Main Business Overview
11.7.5 In-Cell-Art Latest Developments
11.8 eTheRNA
11.8.1 eTheRNA Company Information
11.8.2 eTheRNA mRNA Vaccines for Infectious Diseases Product Offered
11.8.3 eTheRNA mRNA Vaccines for Infectious Diseases Revenue, Gross Margin and Market Share (2018-2023)
11.8.4 eTheRNA Main Business Overview
11.8.5 eTheRNA Latest Developments
11.9 Ethris
11.9.1 Ethris Company Information
11.9.2 Ethris mRNA Vaccines for Infectious Diseases Product Offered
11.9.3 Ethris mRNA Vaccines for Infectious Diseases Revenue, Gross Margin and Market Share (2018-2023)
11.9.4 Ethris Main Business Overview
11.9.5 Ethris Latest Developments
11.10 Tiba Biotechnology
11.10.1 Tiba Biotechnology Company Information
11.10.2 Tiba Biotechnology mRNA Vaccines for Infectious Diseases Product Offered
11.10.3 Tiba Biotechnology mRNA Vaccines for Infectious Diseases Revenue, Gross Margin and Market Share (2018-2023)
11.10.4 Tiba Biotechnology Main Business Overview
11.10.5 Tiba Biotechnology Latest Developments
12 RESEARCH FINDINGS AND CONCLUSION
LIST OF TABLES
Table 1. mRNA Vaccines for Infectious Diseases Market Size CAGR by Region (2018 VS 2022 VS 2029) & ($ Millions)
Table 2. Major Players of Infectious Disease Vaccines
Table 3. Major Players of Cancer Vaccines
Table 4. mRNA Vaccines for Infectious Diseases Market Size CAGR by Type (2018 VS 2022 VS 2029) & ($ Millions)
Table 5. Global mRNA Vaccines for Infectious Diseases Market Size by Type (2018-2023) & ($ Millions)
Table 6. Global mRNA Vaccines for Infectious Diseases Market Size Market Share by Type (2018-2023)
Table 7. mRNA Vaccines for Infectious Diseases Market Size CAGR by Application (2018 VS 2022 VS 2029) & ($ Millions)
Table 8. Global mRNA Vaccines for Infectious Diseases Market Size by Application (2018-2023) & ($ Millions)
Table 9. Global mRNA Vaccines for Infectious Diseases Market Size Market Share by Application (2018-2023)
Table 10. Global mRNA Vaccines for Infectious Diseases Revenue by Players (2018-2023) & ($ Millions)
Table 11. Global mRNA Vaccines for Infectious Diseases Revenue Market Share by Player (2018-2023)
Table 12. mRNA Vaccines for Infectious Diseases Key Players Head office and Products Offered
Table 13. mRNA Vaccines for Infectious Diseases Concentration Ratio (CR3, CR5 and CR10) & (2021-2023)
Table 14. New Products and Potential Entrants
Table 15. Mergers & Acquisitions, Expansion
Table 16. Global mRNA Vaccines for Infectious Diseases Market Size by Regions 2018-2023 & ($ Millions)
Table 17. Global mRNA Vaccines for Infectious Diseases Market Size Market Share by Regions (2018-2023)
Table 18. Global mRNA Vaccines for Infectious Diseases Revenue by Country/Region (2018-2023) & ($ millions)
Table 19. Global mRNA Vaccines for Infectious Diseases Revenue Market Share by Country/Region (2018-2023)
Table 20. Americas mRNA Vaccines for Infectious Diseases Market Size by Country (2018-2023) & ($ Millions)
Table 21. Americas mRNA Vaccines for Infectious Diseases Market Size Market Share by Country (2018-2023)
Table 22. Americas mRNA Vaccines for Infectious Diseases Market Size by Type (2018-2023) & ($ Millions)
Table 23. Americas mRNA Vaccines for Infectious Diseases Market Size Market Share by Type (2018-2023)
Table 24. Americas mRNA Vaccines for Infectious Diseases Market Size by Application (2018-2023) & ($ Millions)
Table 25. Americas mRNA Vaccines for Infectious Diseases Market Size Market Share by Application (2018-2023)
Table 26. APAC mRNA Vaccines for Infectious Diseases Market Size by Region (2018-2023) & ($ Millions)
Table 27. APAC mRNA Vaccines for Infectious Diseases Market Size Market Share by Region (2018-2023)
Table 28. APAC mRNA Vaccines for Infectious Diseases Market Size by Type (2018-2023) & ($ Millions)
Table 29. APAC mRNA Vaccines for Infectious Diseases Market Size Market Share by Type (2018-2023)
Table 30. APAC mRNA Vaccines for Infectious Diseases Market Size by Application (2018-2023) & ($ Millions)
Table 31. APAC mRNA Vaccines for Infectious Diseases Market Size Market Share by Application (2018-2023)
Table 32. Europe mRNA Vaccines for Infectious Diseases Market Size by Country (2018-2023) & ($ Millions)
Table 33. Europe mRNA Vaccines for Infectious Diseases Market Size Market Share by Country (2018-2023)
Table 34. Europe mRNA Vaccines for Infectious Diseases Market Size by Type (2018-2023) & ($ Millions)
Table 35. Europe mRNA Vaccines for Infectious Diseases Market Size Market Share by Type (2018-2023)
Table 36. Europe mRNA Vaccines for Infectious Diseases Market Size by Application (2018-2023) & ($ Millions)
Table 37. Europe mRNA Vaccines for Infectious Diseases Market Size Market Share by Application (2018-2023)
Table 38. Middle East & Africa mRNA Vaccines for Infectious Diseases Market Size by Region (2018-2023) & ($ Millions)
Table 39. Middle East & Africa mRNA Vaccines for Infectious Diseases Market Size Market Share by Region (2018-2023)
Table 40. Middle East & Africa mRNA Vaccines for Infectious Diseases Market Size by Type (2018-2023) & ($ Millions)
Table 41. Middle East & Africa mRNA Vaccines for Infectious Diseases Market Size Market Share by Type (2018-2023)
Table 42. Middle East & Africa mRNA Vaccines for Infectious Diseases Market Size by Application (2018-2023) & ($ Millions)
Table 43. Middle East & Africa mRNA Vaccines for Infectious Diseases Market Size Market Share by Application (2018-2023)
Table 44. Key Market Drivers & Growth Opportunities of mRNA Vaccines for Infectious Diseases
Table 45. Key Market Challenges & Risks of mRNA Vaccines for Infectious Diseases
Table 46. Key Industry Trends of mRNA Vaccines for Infectious Diseases
Table 47. Global mRNA Vaccines for Infectious Diseases Market Size Forecast by Regions (2024-2029) & ($ Millions)
Table 48. Global mRNA Vaccines for Infectious Diseases Market Size Market Share Forecast by Regions (2024-2029)
Table 49. Global mRNA Vaccines for Infectious Diseases Market Size Forecast by Type (2024-2029) & ($ Millions)
Table 50. Global mRNA Vaccines for Infectious Diseases Market Size Forecast by Application (2024-2029) & ($ Millions)
Table 51. Moderna Therapeutics Details, Company Type, mRNA Vaccines for Infectious Diseases Area Served and Its Competitors
Table 52. Moderna Therapeutics mRNA Vaccines for Infectious Diseases Product Offered
Table 53. Moderna Therapeutics mRNA Vaccines for Infectious Diseases Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 54. Moderna Therapeutics Main Business
Table 55. Moderna Therapeutics Latest Developments
Table 56. CureVac Details, Company Type, mRNA Vaccines for Infectious Diseases Area Served and Its Competitors
Table 57. CureVac mRNA Vaccines for Infectious Diseases Product Offered
Table 58. CureVac Main Business
Table 59. CureVac mRNA Vaccines for Infectious Diseases Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 60. CureVac Latest Developments
Table 61. Translate Bio Details, Company Type, mRNA Vaccines for Infectious Diseases Area Served and Its Competitors
Table 62. Translate Bio mRNA Vaccines for Infectious Diseases Product Offered
Table 63. Translate Bio Main Business
Table 64. Translate Bio mRNA Vaccines for Infectious Diseases Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 65. Translate Bio Latest Developments
Table 66. BioNTech Details, Company Type, mRNA Vaccines for Infectious Diseases Area Served and Its Competitors
Table 67. BioNTech mRNA Vaccines for Infectious Diseases Product Offered
Table 68. BioNTech Main Business
Table 69. BioNTech mRNA Vaccines for Infectious Diseases Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 70. BioNTech Latest Developments
Table 71. Sangamo Therapeutics Details, Company Type, mRNA Vaccines for Infectious Diseases Area Served and Its Competitors
Table 72. Sangamo Therapeutics mRNA Vaccines for Infectious Diseases Product Offered
Table 73. Sangamo Therapeutics Main Business
Table 74. Sangamo Therapeutics mRNA Vaccines for Infectious Diseases Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 75. Sangamo Therapeutics Latest Developments
Table 76. Argos Therapeutics Details, Company Type, mRNA Vaccines for Infectious Diseases Area Served and Its Competitors
Table 77. Argos Therapeutics mRNA Vaccines for Infectious Diseases Product Offered
Table 78. Argos Therapeutics Main Business
Table 79. Argos Therapeutics mRNA Vaccines for Infectious Diseases Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 80. Argos Therapeutics Latest Developments
Table 81. In-Cell-Art Details, Company Type, mRNA Vaccines for Infectious Diseases Area Served and Its Competitors
Table 82. In-Cell-Art mRNA Vaccines for Infectious Diseases Product Offered
Table 83. In-Cell-Art Main Business
Table 84. In-Cell-Art mRNA Vaccines for Infectious Diseases Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 85. In-Cell-Art Latest Developments
Table 86. eTheRNA Details, Company Type, mRNA Vaccines for Infectious Diseases Area Served and Its Competitors
Table 87. eTheRNA mRNA Vaccines for Infectious Diseases Product Offered
Table 88. eTheRNA Main Business
Table 89. eTheRNA mRNA Vaccines for Infectious Diseases Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 90. eTheRNA Latest Developments
Table 91. Ethris Details, Company Type, mRNA Vaccines for Infectious Diseases Area Served and Its Competitors
Table 92. Ethris mRNA Vaccines for Infectious Diseases Product Offered
Table 93. Ethris Main Business
Table 94. Ethris mRNA Vaccines for Infectious Diseases Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 95. Ethris Latest Developments
Table 96. Tiba Biotechnology Details, Company Type, mRNA Vaccines for Infectious Diseases Area Served and Its Competitors
Table 97. Tiba Biotechnology mRNA Vaccines for Infectious Diseases Product Offered
Table 98. Tiba Biotechnology Main Business
Table 99. Tiba Biotechnology mRNA Vaccines for Infectious Diseases Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 100. Tiba Biotechnology Latest Developments
Table 1. mRNA Vaccines for Infectious Diseases Market Size CAGR by Region (2018 VS 2022 VS 2029) & ($ Millions)
Table 2. Major Players of Infectious Disease Vaccines
Table 3. Major Players of Cancer Vaccines
Table 4. mRNA Vaccines for Infectious Diseases Market Size CAGR by Type (2018 VS 2022 VS 2029) & ($ Millions)
Table 5. Global mRNA Vaccines for Infectious Diseases Market Size by Type (2018-2023) & ($ Millions)
Table 6. Global mRNA Vaccines for Infectious Diseases Market Size Market Share by Type (2018-2023)
Table 7. mRNA Vaccines for Infectious Diseases Market Size CAGR by Application (2018 VS 2022 VS 2029) & ($ Millions)
Table 8. Global mRNA Vaccines for Infectious Diseases Market Size by Application (2018-2023) & ($ Millions)
Table 9. Global mRNA Vaccines for Infectious Diseases Market Size Market Share by Application (2018-2023)
Table 10. Global mRNA Vaccines for Infectious Diseases Revenue by Players (2018-2023) & ($ Millions)
Table 11. Global mRNA Vaccines for Infectious Diseases Revenue Market Share by Player (2018-2023)
Table 12. mRNA Vaccines for Infectious Diseases Key Players Head office and Products Offered
Table 13. mRNA Vaccines for Infectious Diseases Concentration Ratio (CR3, CR5 and CR10) & (2021-2023)
Table 14. New Products and Potential Entrants
Table 15. Mergers & Acquisitions, Expansion
Table 16. Global mRNA Vaccines for Infectious Diseases Market Size by Regions 2018-2023 & ($ Millions)
Table 17. Global mRNA Vaccines for Infectious Diseases Market Size Market Share by Regions (2018-2023)
Table 18. Global mRNA Vaccines for Infectious Diseases Revenue by Country/Region (2018-2023) & ($ millions)
Table 19. Global mRNA Vaccines for Infectious Diseases Revenue Market Share by Country/Region (2018-2023)
Table 20. Americas mRNA Vaccines for Infectious Diseases Market Size by Country (2018-2023) & ($ Millions)
Table 21. Americas mRNA Vaccines for Infectious Diseases Market Size Market Share by Country (2018-2023)
Table 22. Americas mRNA Vaccines for Infectious Diseases Market Size by Type (2018-2023) & ($ Millions)
Table 23. Americas mRNA Vaccines for Infectious Diseases Market Size Market Share by Type (2018-2023)
Table 24. Americas mRNA Vaccines for Infectious Diseases Market Size by Application (2018-2023) & ($ Millions)
Table 25. Americas mRNA Vaccines for Infectious Diseases Market Size Market Share by Application (2018-2023)
Table 26. APAC mRNA Vaccines for Infectious Diseases Market Size by Region (2018-2023) & ($ Millions)
Table 27. APAC mRNA Vaccines for Infectious Diseases Market Size Market Share by Region (2018-2023)
Table 28. APAC mRNA Vaccines for Infectious Diseases Market Size by Type (2018-2023) & ($ Millions)
Table 29. APAC mRNA Vaccines for Infectious Diseases Market Size Market Share by Type (2018-2023)
Table 30. APAC mRNA Vaccines for Infectious Diseases Market Size by Application (2018-2023) & ($ Millions)
Table 31. APAC mRNA Vaccines for Infectious Diseases Market Size Market Share by Application (2018-2023)
Table 32. Europe mRNA Vaccines for Infectious Diseases Market Size by Country (2018-2023) & ($ Millions)
Table 33. Europe mRNA Vaccines for Infectious Diseases Market Size Market Share by Country (2018-2023)
Table 34. Europe mRNA Vaccines for Infectious Diseases Market Size by Type (2018-2023) & ($ Millions)
Table 35. Europe mRNA Vaccines for Infectious Diseases Market Size Market Share by Type (2018-2023)
Table 36. Europe mRNA Vaccines for Infectious Diseases Market Size by Application (2018-2023) & ($ Millions)
Table 37. Europe mRNA Vaccines for Infectious Diseases Market Size Market Share by Application (2018-2023)
Table 38. Middle East & Africa mRNA Vaccines for Infectious Diseases Market Size by Region (2018-2023) & ($ Millions)
Table 39. Middle East & Africa mRNA Vaccines for Infectious Diseases Market Size Market Share by Region (2018-2023)
Table 40. Middle East & Africa mRNA Vaccines for Infectious Diseases Market Size by Type (2018-2023) & ($ Millions)
Table 41. Middle East & Africa mRNA Vaccines for Infectious Diseases Market Size Market Share by Type (2018-2023)
Table 42. Middle East & Africa mRNA Vaccines for Infectious Diseases Market Size by Application (2018-2023) & ($ Millions)
Table 43. Middle East & Africa mRNA Vaccines for Infectious Diseases Market Size Market Share by Application (2018-2023)
Table 44. Key Market Drivers & Growth Opportunities of mRNA Vaccines for Infectious Diseases
Table 45. Key Market Challenges & Risks of mRNA Vaccines for Infectious Diseases
Table 46. Key Industry Trends of mRNA Vaccines for Infectious Diseases
Table 47. Global mRNA Vaccines for Infectious Diseases Market Size Forecast by Regions (2024-2029) & ($ Millions)
Table 48. Global mRNA Vaccines for Infectious Diseases Market Size Market Share Forecast by Regions (2024-2029)
Table 49. Global mRNA Vaccines for Infectious Diseases Market Size Forecast by Type (2024-2029) & ($ Millions)
Table 50. Global mRNA Vaccines for Infectious Diseases Market Size Forecast by Application (2024-2029) & ($ Millions)
Table 51. Moderna Therapeutics Details, Company Type, mRNA Vaccines for Infectious Diseases Area Served and Its Competitors
Table 52. Moderna Therapeutics mRNA Vaccines for Infectious Diseases Product Offered
Table 53. Moderna Therapeutics mRNA Vaccines for Infectious Diseases Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 54. Moderna Therapeutics Main Business
Table 55. Moderna Therapeutics Latest Developments
Table 56. CureVac Details, Company Type, mRNA Vaccines for Infectious Diseases Area Served and Its Competitors
Table 57. CureVac mRNA Vaccines for Infectious Diseases Product Offered
Table 58. CureVac Main Business
Table 59. CureVac mRNA Vaccines for Infectious Diseases Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 60. CureVac Latest Developments
Table 61. Translate Bio Details, Company Type, mRNA Vaccines for Infectious Diseases Area Served and Its Competitors
Table 62. Translate Bio mRNA Vaccines for Infectious Diseases Product Offered
Table 63. Translate Bio Main Business
Table 64. Translate Bio mRNA Vaccines for Infectious Diseases Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 65. Translate Bio Latest Developments
Table 66. BioNTech Details, Company Type, mRNA Vaccines for Infectious Diseases Area Served and Its Competitors
Table 67. BioNTech mRNA Vaccines for Infectious Diseases Product Offered
Table 68. BioNTech Main Business
Table 69. BioNTech mRNA Vaccines for Infectious Diseases Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 70. BioNTech Latest Developments
Table 71. Sangamo Therapeutics Details, Company Type, mRNA Vaccines for Infectious Diseases Area Served and Its Competitors
Table 72. Sangamo Therapeutics mRNA Vaccines for Infectious Diseases Product Offered
Table 73. Sangamo Therapeutics Main Business
Table 74. Sangamo Therapeutics mRNA Vaccines for Infectious Diseases Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 75. Sangamo Therapeutics Latest Developments
Table 76. Argos Therapeutics Details, Company Type, mRNA Vaccines for Infectious Diseases Area Served and Its Competitors
Table 77. Argos Therapeutics mRNA Vaccines for Infectious Diseases Product Offered
Table 78. Argos Therapeutics Main Business
Table 79. Argos Therapeutics mRNA Vaccines for Infectious Diseases Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 80. Argos Therapeutics Latest Developments
Table 81. In-Cell-Art Details, Company Type, mRNA Vaccines for Infectious Diseases Area Served and Its Competitors
Table 82. In-Cell-Art mRNA Vaccines for Infectious Diseases Product Offered
Table 83. In-Cell-Art Main Business
Table 84. In-Cell-Art mRNA Vaccines for Infectious Diseases Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 85. In-Cell-Art Latest Developments
Table 86. eTheRNA Details, Company Type, mRNA Vaccines for Infectious Diseases Area Served and Its Competitors
Table 87. eTheRNA mRNA Vaccines for Infectious Diseases Product Offered
Table 88. eTheRNA Main Business
Table 89. eTheRNA mRNA Vaccines for Infectious Diseases Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 90. eTheRNA Latest Developments
Table 91. Ethris Details, Company Type, mRNA Vaccines for Infectious Diseases Area Served and Its Competitors
Table 92. Ethris mRNA Vaccines for Infectious Diseases Product Offered
Table 93. Ethris Main Business
Table 94. Ethris mRNA Vaccines for Infectious Diseases Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 95. Ethris Latest Developments
Table 96. Tiba Biotechnology Details, Company Type, mRNA Vaccines for Infectious Diseases Area Served and Its Competitors
Table 97. Tiba Biotechnology mRNA Vaccines for Infectious Diseases Product Offered
Table 98. Tiba Biotechnology Main Business
Table 99. Tiba Biotechnology mRNA Vaccines for Infectious Diseases Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 100. Tiba Biotechnology Latest Developments
LIST OF FIGURES
Figure 1. mRNA Vaccines for Infectious Diseases Report Years Considered
Figure 2. Research Objectives
Figure 3. Research Methodology
Figure 4. Research Process and Data Source
Figure 5. Global mRNA Vaccines for Infectious Diseases Market Size Growth Rate 2018-2029 ($ Millions)
Figure 6. mRNA Vaccines for Infectious Diseases Sales by Geographic Region (2018, 2022 & 2029) & ($ millions)
Figure 7. mRNA Vaccines for Infectious Diseases Sales Market Share by Country/Region (2022)
Figure 8. mRNA Vaccines for Infectious Diseases Sales Market Share by Country/Region (2018, 2022 & 2029)
Figure 9. Global mRNA Vaccines for Infectious Diseases Market Size Market Share by Type in 2022
Figure 10. mRNA Vaccines for Infectious Diseases in Infectious Disease
Figure 11. Global mRNA Vaccines for Infectious Diseases Market: Infectious Disease (2018-2023) & ($ Millions)
Figure 12. mRNA Vaccines for Infectious Diseases in Cancer
Figure 13. Global mRNA Vaccines for Infectious Diseases Market: Cancer (2018-2023) & ($ Millions)
Figure 14. Global mRNA Vaccines for Infectious Diseases Market Size Market Share by Application in 2022
Figure 15. Global mRNA Vaccines for Infectious Diseases Revenue Market Share by Player in 2022
Figure 16. Global mRNA Vaccines for Infectious Diseases Market Size Market Share by Regions (2018-2023)
Figure 17. Americas mRNA Vaccines for Infectious Diseases Market Size 2018-2023 ($ Millions)
Figure 18. APAC mRNA Vaccines for Infectious Diseases Market Size 2018-2023 ($ Millions)
Figure 19. Europe mRNA Vaccines for Infectious Diseases Market Size 2018-2023 ($ Millions)
Figure 20. Middle East & Africa mRNA Vaccines for Infectious Diseases Market Size 2018-2023 ($ Millions)
Figure 21. Americas mRNA Vaccines for Infectious Diseases Value Market Share by Country in 2022
Figure 22. United States mRNA Vaccines for Infectious Diseases Market Size Growth 2018-2023 ($ Millions)
Figure 23. Canada mRNA Vaccines for Infectious Diseases Market Size Growth 2018-2023 ($ Millions)
Figure 24. Mexico mRNA Vaccines for Infectious Diseases Market Size Growth 2018-2023 ($ Millions)
Figure 25. Brazil mRNA Vaccines for Infectious Diseases Market Size Growth 2018-2023 ($ Millions)
Figure 26. APAC mRNA Vaccines for Infectious Diseases Market Size Market Share by Region in 2022
Figure 27. APAC mRNA Vaccines for Infectious Diseases Market Size Market Share by Type in 2022
Figure 28. APAC mRNA Vaccines for Infectious Diseases Market Size Market Share by Application in 2022
Figure 29. China mRNA Vaccines for Infectious Diseases Market Size Growth 2018-2023 ($ Millions)
Figure 30. Japan mRNA Vaccines for Infectious Diseases Market Size Growth 2018-2023 ($ Millions)
Figure 31. Korea mRNA Vaccines for Infectious Diseases Market Size Growth 2018-2023 ($ Millions)
Figure 32. Southeast Asia mRNA Vaccines for Infectious Diseases Market Size Growth 2018-2023 ($ Millions)
Figure 33. India mRNA Vaccines for Infectious Diseases Market Size Growth 2018-2023 ($ Millions)
Figure 34. Australia mRNA Vaccines for Infectious Diseases Market Size Growth 2018-2023 ($ Millions)
Figure 35. Europe mRNA Vaccines for Infectious Diseases Market Size Market Share by Country in 2022
Figure 36. Europe mRNA Vaccines for Infectious Diseases Market Size Market Share by Type (2018-2023)
Figure 37. Europe mRNA Vaccines for Infectious Diseases Market Size Market Share by Application (2018-2023)
Figure 38. Germany mRNA Vaccines for Infectious Diseases Market Size Growth 2018-2023 ($ Millions)
Figure 39. France mRNA Vaccines for Infectious Diseases Market Size Growth 2018-2023 ($ Millions)
Figure 40. UK mRNA Vaccines for Infectious Diseases Market Size Growth 2018-2023 ($ Millions)
Figure 41. Italy mRNA Vaccines for Infectious Diseases Market Size Growth 2018-2023 ($ Millions)
Figure 42. Russia mRNA Vaccines for Infectious Diseases Market Size Growth 2018-2023 ($ Millions)
Figure 43. Middle East & Africa mRNA Vaccines for Infectious Diseases Market Size Market Share by Region (2018-2023)
Figure 44. Middle East & Africa mRNA Vaccines for Infectious Diseases Market Size Market Share by Type (2018-2023)
Figure 45. Middle East & Africa mRNA Vaccines for Infectious Diseases Market Size Market Share by Application (2018-2023)
Figure 46. Egypt mRNA Vaccines for Infectious Diseases Market Size Growth 2018-2023 ($ Millions)
Figure 47. South Africa mRNA Vaccines for Infectious Diseases Market Size Growth 2018-2023 ($ Millions)
Figure 48. Israel mRNA Vaccines for Infectious Diseases Market Size Growth 2018-2023 ($ Millions)
Figure 49. Turkey mRNA Vaccines for Infectious Diseases Market Size Growth 2018-2023 ($ Millions)
Figure 50. GCC Country mRNA Vaccines for Infectious Diseases Market Size Growth 2018-2023 ($ Millions)
Figure 51. Americas mRNA Vaccines for Infectious Diseases Market Size 2024-2029 ($ Millions)
Figure 52. APAC mRNA Vaccines for Infectious Diseases Market Size 2024-2029 ($ Millions)
Figure 53. Europe mRNA Vaccines for Infectious Diseases Market Size 2024-2029 ($ Millions)
Figure 54. Middle East & Africa mRNA Vaccines for Infectious Diseases Market Size 2024-2029 ($ Millions)
Figure 55. United States mRNA Vaccines for Infectious Diseases Market Size 2024-2029 ($ Millions)
Figure 56. Canada mRNA Vaccines for Infectious Diseases Market Size 2024-2029 ($ Millions)
Figure 57. Mexico mRNA Vaccines for Infectious Diseases Market Size 2024-2029 ($ Millions)
Figure 58. Brazil mRNA Vaccines for Infectious Diseases Market Size 2024-2029 ($ Millions)
Figure 59. China mRNA Vaccines for Infectious Diseases Market Size 2024-2029 ($ Millions)
Figure 60. Japan mRNA Vaccines for Infectious Diseases Market Size 2024-2029 ($ Millions)
Figure 61. Korea mRNA Vaccines for Infectious Diseases Market Size 2024-2029 ($ Millions)
Figure 62. Southeast Asia mRNA Vaccines for Infectious Diseases Market Size 2024-2029 ($ Millions)
Figure 63. India mRNA Vaccines for Infectious Diseases Market Size 2024-2029 ($ Millions)
Figure 64. Australia mRNA Vaccines for Infectious Diseases Market Size 2024-2029 ($ Millions)
Figure 65. Germany mRNA Vaccines for Infectious Diseases Market Size 2024-2029 ($ Millions)
Figure 66. France mRNA Vaccines for Infectious Diseases Market Size 2024-2029 ($ Millions)
Figure 67. UK mRNA Vaccines for Infectious Diseases Market Size 2024-2029 ($ Millions)
Figure 68. Italy mRNA Vaccines for Infectious Diseases Market Size 2024-2029 ($ Millions)
Figure 69. Russia mRNA Vaccines for Infectious Diseases Market Size 2024-2029 ($ Millions)
Figure 70. Spain mRNA Vaccines for Infectious Diseases Market Size 2024-2029 ($ Millions)
Figure 71. Egypt mRNA Vaccines for Infectious Diseases Market Size 2024-2029 ($ Millions)
Figure 72. South Africa mRNA Vaccines for Infectious Diseases Market Size 2024-2029 ($ Millions)
Figure 73. Israel mRNA Vaccines for Infectious Diseases Market Size 2024-2029 ($ Millions)
Figure 74. Turkey mRNA Vaccines for Infectious Diseases Market Size 2024-2029 ($ Millions)
Figure 75. GCC Countries mRNA Vaccines for Infectious Diseases Market Size 2024-2029 ($ Millions)
Figure 76. Global mRNA Vaccines for Infectious Diseases Market Size Market Share Forecast by Type (2024-2029)
Figure 77. Global mRNA Vaccines for Infectious Diseases Market Size Market Share Forecast by Application (2024-2029)
Figure 1. mRNA Vaccines for Infectious Diseases Report Years Considered
Figure 2. Research Objectives
Figure 3. Research Methodology
Figure 4. Research Process and Data Source
Figure 5. Global mRNA Vaccines for Infectious Diseases Market Size Growth Rate 2018-2029 ($ Millions)
Figure 6. mRNA Vaccines for Infectious Diseases Sales by Geographic Region (2018, 2022 & 2029) & ($ millions)
Figure 7. mRNA Vaccines for Infectious Diseases Sales Market Share by Country/Region (2022)
Figure 8. mRNA Vaccines for Infectious Diseases Sales Market Share by Country/Region (2018, 2022 & 2029)
Figure 9. Global mRNA Vaccines for Infectious Diseases Market Size Market Share by Type in 2022
Figure 10. mRNA Vaccines for Infectious Diseases in Infectious Disease
Figure 11. Global mRNA Vaccines for Infectious Diseases Market: Infectious Disease (2018-2023) & ($ Millions)
Figure 12. mRNA Vaccines for Infectious Diseases in Cancer
Figure 13. Global mRNA Vaccines for Infectious Diseases Market: Cancer (2018-2023) & ($ Millions)
Figure 14. Global mRNA Vaccines for Infectious Diseases Market Size Market Share by Application in 2022
Figure 15. Global mRNA Vaccines for Infectious Diseases Revenue Market Share by Player in 2022
Figure 16. Global mRNA Vaccines for Infectious Diseases Market Size Market Share by Regions (2018-2023)
Figure 17. Americas mRNA Vaccines for Infectious Diseases Market Size 2018-2023 ($ Millions)
Figure 18. APAC mRNA Vaccines for Infectious Diseases Market Size 2018-2023 ($ Millions)
Figure 19. Europe mRNA Vaccines for Infectious Diseases Market Size 2018-2023 ($ Millions)
Figure 20. Middle East & Africa mRNA Vaccines for Infectious Diseases Market Size 2018-2023 ($ Millions)
Figure 21. Americas mRNA Vaccines for Infectious Diseases Value Market Share by Country in 2022
Figure 22. United States mRNA Vaccines for Infectious Diseases Market Size Growth 2018-2023 ($ Millions)
Figure 23. Canada mRNA Vaccines for Infectious Diseases Market Size Growth 2018-2023 ($ Millions)
Figure 24. Mexico mRNA Vaccines for Infectious Diseases Market Size Growth 2018-2023 ($ Millions)
Figure 25. Brazil mRNA Vaccines for Infectious Diseases Market Size Growth 2018-2023 ($ Millions)
Figure 26. APAC mRNA Vaccines for Infectious Diseases Market Size Market Share by Region in 2022
Figure 27. APAC mRNA Vaccines for Infectious Diseases Market Size Market Share by Type in 2022
Figure 28. APAC mRNA Vaccines for Infectious Diseases Market Size Market Share by Application in 2022
Figure 29. China mRNA Vaccines for Infectious Diseases Market Size Growth 2018-2023 ($ Millions)
Figure 30. Japan mRNA Vaccines for Infectious Diseases Market Size Growth 2018-2023 ($ Millions)
Figure 31. Korea mRNA Vaccines for Infectious Diseases Market Size Growth 2018-2023 ($ Millions)
Figure 32. Southeast Asia mRNA Vaccines for Infectious Diseases Market Size Growth 2018-2023 ($ Millions)
Figure 33. India mRNA Vaccines for Infectious Diseases Market Size Growth 2018-2023 ($ Millions)
Figure 34. Australia mRNA Vaccines for Infectious Diseases Market Size Growth 2018-2023 ($ Millions)
Figure 35. Europe mRNA Vaccines for Infectious Diseases Market Size Market Share by Country in 2022
Figure 36. Europe mRNA Vaccines for Infectious Diseases Market Size Market Share by Type (2018-2023)
Figure 37. Europe mRNA Vaccines for Infectious Diseases Market Size Market Share by Application (2018-2023)
Figure 38. Germany mRNA Vaccines for Infectious Diseases Market Size Growth 2018-2023 ($ Millions)
Figure 39. France mRNA Vaccines for Infectious Diseases Market Size Growth 2018-2023 ($ Millions)
Figure 40. UK mRNA Vaccines for Infectious Diseases Market Size Growth 2018-2023 ($ Millions)
Figure 41. Italy mRNA Vaccines for Infectious Diseases Market Size Growth 2018-2023 ($ Millions)
Figure 42. Russia mRNA Vaccines for Infectious Diseases Market Size Growth 2018-2023 ($ Millions)
Figure 43. Middle East & Africa mRNA Vaccines for Infectious Diseases Market Size Market Share by Region (2018-2023)
Figure 44. Middle East & Africa mRNA Vaccines for Infectious Diseases Market Size Market Share by Type (2018-2023)
Figure 45. Middle East & Africa mRNA Vaccines for Infectious Diseases Market Size Market Share by Application (2018-2023)
Figure 46. Egypt mRNA Vaccines for Infectious Diseases Market Size Growth 2018-2023 ($ Millions)
Figure 47. South Africa mRNA Vaccines for Infectious Diseases Market Size Growth 2018-2023 ($ Millions)
Figure 48. Israel mRNA Vaccines for Infectious Diseases Market Size Growth 2018-2023 ($ Millions)
Figure 49. Turkey mRNA Vaccines for Infectious Diseases Market Size Growth 2018-2023 ($ Millions)
Figure 50. GCC Country mRNA Vaccines for Infectious Diseases Market Size Growth 2018-2023 ($ Millions)
Figure 51. Americas mRNA Vaccines for Infectious Diseases Market Size 2024-2029 ($ Millions)
Figure 52. APAC mRNA Vaccines for Infectious Diseases Market Size 2024-2029 ($ Millions)
Figure 53. Europe mRNA Vaccines for Infectious Diseases Market Size 2024-2029 ($ Millions)
Figure 54. Middle East & Africa mRNA Vaccines for Infectious Diseases Market Size 2024-2029 ($ Millions)
Figure 55. United States mRNA Vaccines for Infectious Diseases Market Size 2024-2029 ($ Millions)
Figure 56. Canada mRNA Vaccines for Infectious Diseases Market Size 2024-2029 ($ Millions)
Figure 57. Mexico mRNA Vaccines for Infectious Diseases Market Size 2024-2029 ($ Millions)
Figure 58. Brazil mRNA Vaccines for Infectious Diseases Market Size 2024-2029 ($ Millions)
Figure 59. China mRNA Vaccines for Infectious Diseases Market Size 2024-2029 ($ Millions)
Figure 60. Japan mRNA Vaccines for Infectious Diseases Market Size 2024-2029 ($ Millions)
Figure 61. Korea mRNA Vaccines for Infectious Diseases Market Size 2024-2029 ($ Millions)
Figure 62. Southeast Asia mRNA Vaccines for Infectious Diseases Market Size 2024-2029 ($ Millions)
Figure 63. India mRNA Vaccines for Infectious Diseases Market Size 2024-2029 ($ Millions)
Figure 64. Australia mRNA Vaccines for Infectious Diseases Market Size 2024-2029 ($ Millions)
Figure 65. Germany mRNA Vaccines for Infectious Diseases Market Size 2024-2029 ($ Millions)
Figure 66. France mRNA Vaccines for Infectious Diseases Market Size 2024-2029 ($ Millions)
Figure 67. UK mRNA Vaccines for Infectious Diseases Market Size 2024-2029 ($ Millions)
Figure 68. Italy mRNA Vaccines for Infectious Diseases Market Size 2024-2029 ($ Millions)
Figure 69. Russia mRNA Vaccines for Infectious Diseases Market Size 2024-2029 ($ Millions)
Figure 70. Spain mRNA Vaccines for Infectious Diseases Market Size 2024-2029 ($ Millions)
Figure 71. Egypt mRNA Vaccines for Infectious Diseases Market Size 2024-2029 ($ Millions)
Figure 72. South Africa mRNA Vaccines for Infectious Diseases Market Size 2024-2029 ($ Millions)
Figure 73. Israel mRNA Vaccines for Infectious Diseases Market Size 2024-2029 ($ Millions)
Figure 74. Turkey mRNA Vaccines for Infectious Diseases Market Size 2024-2029 ($ Millions)
Figure 75. GCC Countries mRNA Vaccines for Infectious Diseases Market Size 2024-2029 ($ Millions)
Figure 76. Global mRNA Vaccines for Infectious Diseases Market Size Market Share Forecast by Type (2024-2029)
Figure 77. Global mRNA Vaccines for Infectious Diseases Market Size Market Share Forecast by Application (2024-2029)
